CONSIDERATIONS TO KNOW ABOUT HEMGENIX

Variety of qualified clients: CDEC discussed the uncertainty in the number of people with moderately serious to extreme hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some sufferers who're categorized as getting mild or average sickness can have a critical bleeding phenotype,